The US Food and Drug Administration has approved an over-the-air software upgrade for Infinity implants manufactured by Abbott, giving devices used in Parkinson’s and essential tremor full-
AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).